These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9096907)

  • 1. Impact of terminal heat sterilization on the quality of peritoneal dialysis solutions.
    Martis L; Henderson LW
    Blood Purif; 1997; 15(1):54-60. PubMed ID: 9096907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The challenges of heat sterilization of peritoneal dialysis solutions: is there an alternative?
    Hanrahan CT; Himmele R; Diaz-Buxo JA
    Adv Perit Dial; 2012; 28():126-30. PubMed ID: 23311228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat sterilization of peritoneal dialysis solutions influences ingestive behavior in non-uremic rats.
    Zheng ZH; Anderstam B; Qureshi AR; Heimbürger O; Wang T; Södersten P; Bergström J; Lindholm B
    Kidney Int; 2002 Oct; 62(4):1447-53. PubMed ID: 12234318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro.
    Cendoroglo M; Sundaram S; Jaber BL; Pereira BJ
    Am J Kidney Dis; 1998 Feb; 31(2):273-82. PubMed ID: 9469498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity of heat sterilized peritoneal dialysis fluids is derived from degradation of glucose.
    Martinson E; Wieslander A; Kjellstrand P; Boberg U
    ASAIO J; 1992; 38(3):M370-2. PubMed ID: 1457884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis].
    Haag-Weber M
    Wien Klin Wochenschr; 2005; 117 Suppl 6():89-97. PubMed ID: 16437339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration.
    Morgan LW; Wieslander A; Davies M; Horiuchi T; Ohta Y; Beavis MJ; Craig KJ; Williams JD; Topley N
    Kidney Int; 2003 Nov; 64(5):1854-66. PubMed ID: 14531821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation in peritoneal dialysis fluids may be avoided by using low pH and high glucose concentration.
    Kjellstrand P; Martinson E; Wieslander A; Kjellstrand K; Jeppsson E; Svensson E; Järkelid L; Linden T; Olsson LF
    Perit Dial Int; 2001; 21(4):338-44. PubMed ID: 11587395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose degradation products (GDP's) and peritoneal changes in patients on chronic peritoneal dialysis: will new dialysis solutions prevent these changes?
    Krishnan M; Tam P; Wu G; Breborowicz A; Oreopoulos DG
    Int Urol Nephrol; 2005; 37(2):409-18. PubMed ID: 16142577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological significance of reducing glucose degradation products in peritoneal dialysis fluids.
    Wieslander A; Linden T; Musi B; Carlsson O; Deppisch R
    Perit Dial Int; 2000; 20 Suppl 5():S23-7. PubMed ID: 11229608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for Biocompatible Peritoneal Dialysis Solutions.
    Nataatmadja M; Cho Y; Johnson DW
    Contrib Nephrol; 2017; 189():91-101. PubMed ID: 27951555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose degradation products in peritoneal dialysis: from bench to bedside.
    Jörres A
    Kidney Blood Press Res; 2003; 26(2):113-7. PubMed ID: 12771536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat-sterilized PD fluid blocks leukocyte adhesion and increases flow velocity in rat peritoneal venules.
    Jonasson P; Bagge U; Wieslander A; Braide M
    Perit Dial Int; 1996; 16 Suppl 1():S137-40. PubMed ID: 8728180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of 3,4-dideoxyglucosone-3-ene (3,4-DGE) on cytotoxicity of acidic heat-sterilized peritoneal dialysis fluid.
    Tomo T; Okabe E; Yamamoto T; Namoto S; Iwashita T; Matsuyama K; Kadota J
    J Artif Organs; 2007; 10(1):47-51. PubMed ID: 17380297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temperature: the single most important factor for degradation of glucose fluids during storage.
    Kjellstrand P; Erixon M; Wieslander A; Lindén T; Martinson E
    Perit Dial Int; 2004; 24(4):385-91. PubMed ID: 15335154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-omics comparison of stress responses in mesothelial cells exposed to heat- versus filter-sterilized peritoneal dialysis fluids.
    Kratochwill K; Bender TO; Lichtenauer AM; Herzog R; Tarantino S; Bialas K; Jörres A; Aufricht C
    Biomed Res Int; 2015; 2015():628158. PubMed ID: 26495307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to avoid glucose degradation products in peritoneal dialysis fluids.
    Erixon M; Wieslander A; Lindén T; Carlsson O; Forsbäck G; Svensson E; Jönsson JA; Kjellstrand P
    Perit Dial Int; 2006; 26(4):490-7. PubMed ID: 16881345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of toxic degradation products during heat sterilization of glucose-containing fluids for peritoneal dialysis: influence of time and temperature.
    Kjellstrand P; Martinson E; Wieslander A; Holmquist B
    Perit Dial Int; 1995; 15(1):26-32. PubMed ID: 7734557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peritoneal dialysis solutions].
    Montenegro J
    Nefrologia; 2008; 28 Suppl 5():59-65. PubMed ID: 18847422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective multicenter observational study of encapsulating peritoneal sclerosis with neutral dialysis solution--the NEXT-PD study.
    Kawanishi H; Nakayama M; Miyazaki M; Honda K; Tomo T; Kasai K; Nakamoto H;
    Adv Perit Dial; 2010; 26():71-4. PubMed ID: 21348384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.